Current challenges in the management of prolactinomas
(2015) European Endocrinology — Vol. 11, n° 1, p. 39-40 (2015)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- Although the diagnosis of prolactinoma is often straightforward and the treatment strategy has been well defined in recent guidelines, several challenging issues persist in their management. The differential diagnosis of a large pituitary tumour with moderately elevated prolactin (PRL) concentrations is sometimes difficult, and prolonged treatment with a dopamine agonist may be inappropriate when the diagnosis of a prolactinoma is not sufficiently well substantiated. Also, timely withdrawal of dopamine agonist treatment and the remaining indications of transsphenoidal surgery are still matters of debate. Last but not least, the management of resistant or aggressive prolactinomas remains a challenge for the clinician, especially when they occur in young patients.
- Affiliations
Citations
Maiter, D. (2015). Current challenges in the management of prolactinomas. European Endocrinology, 11(1), 39-40. https://doi.org/10.1210/MTP3.9781936704835.ch37 (Original work published 2015)